You’ll also support fund groundbreaking analysis that brings us closer to a cure. Arthritis is relentless, but so are we. Unleash your generosity! Further more treatment options like bDMARDs, tsDMARDs, biosimilars or mix therapy are available when csDMARDs are ineffective or improperly tolerated. bDMARDs are a more recent option for https://www.directivepublications.org/journal-of-arthritis-and-rheumatology/